Journal of the Formosan Medical Association
Volume 107, Issue 5 , Pages 404-411, May 2008

Seroprevalence of Viral Hepatitis and Sexually Transmitted Disease Among Adults with Recently Diagnosed HIV Infection in Southern Taiwan, 2000–2005: Upsurge in Hepatitis C Virus Infections Among Injection Drug Users

  • Hsin-Chun Lee

      Affiliations

    • Department of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan
    • Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan
  • ,
  • Nai-Ying Ko

      Affiliations

    • Department of Nursing, College of Medicine, National Cheng Kung University, Tainan, Taiwan
  • ,
  • Nan-Yao Lee

      Affiliations

    • Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan
  • ,
  • Chia-Ming Chang

      Affiliations

    • Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan
  • ,
  • Wen-Chien Ko

      Affiliations

    • Department of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan
    • Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan
    • Corresponding Author InformationCorrespondence to: Dr Wen-Chien Ko, Department of Internal Medicine, National Cheng Kung University Hospital, 138 Sheng Li Road, Tainan 704, Taiwan

Received 15 November 2007; received in revised form 22 January 2008; accepted 12 February 2008.

Article Outline

Background/Purpose

The purpose of this study was to compare the seroprevalence of viral hepatitis and sexually transmitted disease (STD) co-infections among three populations at risk recently diagnosed with HIV infection.

Methods

A retrospective review of medical records was performed to determine the prevalence of several co-infections among adults recently diagnosed with HIV infection between 2000 and 2005 at National Cheng Kung University Hospital in Tainan, Taiwan.

Results

Among a total of 484 adults, 124 (25.6%) were men having sex with men (MSM), 105 (21.7%) were heterosexual adults, and 255 (52.7%) were injection drug users (IDUs). The case number of adults with recently diagnosed HIV infection increased annually, from 27 in 2000 to 142 in 2005 (p < 0.001). This trend appeared to be attributable to the upsurge in HIV infection among IDUs beginning in 2003. At the time of HIV diagnosis, mean CD4+ counts were significantly higher and plasma HIV-1 RNA loads were lower in the IDU group than the MSM or heterosexual groups. The hepatitis B virus (HBV) carrier rate was similar in all three groups, with an average rate of 16.5%. The prevalence of treponemal antibody and Entamoeba histolytica indirect hemagglutination antibody was higher in MSM (37.5% and 9.4%, respectively) than in heterosexuals (19.6% and 7.3%, respectively) or IDUs (3.2% and 2.1%). The seroprevalence of hepatitis A virus infection increased with age, with 94.2% (97/103) of patients who were older than 40 years. Hepatitis C virus (HCV) or HBV-HCV co-infections were noted more often in IDUs (97.9% and 16.9%, respectively) than in heterosexuals (10.9% and 2.2%, respectively) and MSM (5.3% and 3.6%, respectively).

Conclusion

There was a recent upsurge in HIV-HCV co-infected IDUs in southern Taiwan. A higher rate of co-infection with STDs among HIV-infected MSM highlights the need for integrated STD control efforts in current HIV prevention programs.

Key Words:  human immunodeficiency virus , sexually transmitted diseases , transmission routes , viral hepatitis

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Twu SJ , Huang YF , Lai AC , et al.   Update and projection on HIV/AIDS in Taiwan . AIDS Educ Prev . 2004;16:53–63
  2. Chen YM , Lan YC , Lai SF , et al.   HIV-1 CRF07_BC infections, injecting drug users, Taiwan . Emerg Infect Dis . 2006;12:703–705
  3. Lin HH , Shih YL , Liu YC , et al.   An epidemic of HIV type I CRF07_BC infection among injection drug users in Taiwan . J Acquir Immune Defic Syndr . 2006;42:248–255
  4. Verucchi G , Calza L , Manfredi R , et al.   Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management . Infection . 2004;32:33–46
  5. Amin J , Kaye M , Skidmore S , et al.   HIV and hepatitis C coinfection within the CAESAR study . HIV Med . 2004;5:174–179
  6. Lincoln D , Petoumenos K , Dore GJ . HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy . HIV Med . 2003;4:241–249
  7. Agwale SM , Tanimoto L , Womack C , et al.   Prevalence of HCV coinfection in HIV-infected individuals in Nigeria and characterization of HCV genotypes . J Clin Virol . 2004;31(Suppl 1):S3–S6
  8. Padmapriyadarsini C , Chandrabose J , Victor L , et al.   Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function . J Postgrad Med . 2006;52:92–96
  9. Konopnicki D , Mocroft A , de WS , et al.   Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort . AIDS . 2005;19:593–601
  10. Joffe H , Bamberger E , Nurkin S , et al.   Sexually transmitted diseases among patients with human immunodeficiency virus in northern Israel . Isr Med Assoc J . 2006;8:333–336
  11. Chen SC , Wang ST , Chen KT , et al.   Analysis of the influence of therapy and viral suppression on high-risk sexual behaviour and sexually transmitted infections among patients infected with human immunodeficiency virus in Taiwan . Clin Microbiol Infect . 2006;12:660–665
  12. McGowan JP , Shah SS , Ganea CE , et al.   Risk behavior for transmission of human immunodeficiency virus (HIV) among HIV-seropositive individuals in an urban setting . Clin Infect Dis . 2004;38:122–127
  13. Erbelding EJ , Chung SE , Kamb ML , et al.   New sexually transmitted diseases in HIV-infected patients: markers for ongoing HIV transmission behavior . J Acquir Immune Defic Syndr . 2003;33:247–252
  14. Garten RJ , Zhang J , Lai S , et al.   Coinfection with HIV and hepatitis C virus among injection drug users in southern China . Clin Infect Dis . 2005;41(Suppl 1):S18–S24
  15. Bonacini M , Louie S , Bzowej N , et al.   Survival in patients with HIV infection and viral hepatitis B or C: a cohort study . AIDS . 2004;18:2039–2045
  16. De LA , Bugarini R , Lepri AC , et al.   Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects . Arch Intern Med . 2002;162:2125–2132
  17. Chien YC , Jan CF , Kuo HS , et al.   Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched . Epidemiol Rev . 2006;28:126–135
  18. Lai MY . Combined interferon and ribavirin therapy for chronic hepatitis C in Taiwan . Intervirology . 2006;49:91–95
  19. Center for Disease Control  . HIV/AIDS . Available at http://www.cdc.gov.tw/file/39106_3526388889.xls [Date accessed: May 20, 2007] Taipei, Taiwan: Center for Disease Control, 2007. [In Chinese]
  20. Hung CC , Chang SC . Impact of highly active antiretroviral therapy on incidence and management of human immunodeficiency virus-related opportunistic infections . J Antimicrob Chemother . 2004;54:849–853
  21. Hung CC , Hsiao CF , Chen MY , et al.   Improved survival of persons with human immunodeficiency virus type 1 infection in the era of highly active antiretroviral therapy in Taiwan . Jpn J Infect Dis . 2006;59:222–228
  22. Fang CT , Hsu HM , Twu SJ , et al.   Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan . J Infect Dis . 2004;190:879–885
  23. Chen YM , Kuo SH . HIV-1 in Taiwan . Lancet . 2007;369:623–625
  24. Lee SD , Chan CY , Wang YJ , et al.   Seroepidemiology of hepatitis C virus infection in Taiwan . Hepatology . 1991;13:830–833
  25. Chang CJ , Ko YC , Liu HW . Seroepidemiology of hepatitis C virus infection among drug abusers in southern Taiwan . J Formos Med Assoc . 1998;97:826–829
  26. Chang CJ , Lin CH , Lee CT , et al.   Hepatitis C virus infection among short-term intravenous drug users in southern Taiwan . Eur J Epidemiol . 1999;15:597–601
  27. Wu JS , Lu CF , Liu WT , et al.   Prevalence of antibodies to hepatitis C virus (anti-HCV) in different populations in Taiwan . Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi . 1991;24:55–60
  28. Wang JT , Wang TH , Lin JT , et al.   Effect of hepatitis C antibody screening in blood donors on post-transfusion hepatitis in Taiwan . J Gastroenterol Hepatol . 1995;10:454–458
  29. Yang CS , Chang HH , Chou CC , et al.   Isolation effectively prevents the transmission of hepatitis C virus in the hemodialysis unit . J Formos Med Assoc . 2003;102:79–85
  30. Chen CK , Su LW , Lin SK . Characteristics of hospitalized heroin smokers and heroin injectors in Taiwan . Changgeng Yi Xue Za Zhi . 1999;22:197–203
  31. Barzaga BN . Hepatitis A shifting epidemiology in SouthEast Asia and China . Vaccine . 2000;18(Suppl 1):S61–S64
  32. Wang SM , Liu CC , Huang YS , et al.   Change in hepatitis A virus seroepidemiology in southern Taiwan: a large percentage of the population lack protective antibody . J Med Virol . 2001;64:104–108
  33. Hung CC , Deng HY , Hsiao WH , et al.   Invasive amebiasis as an emerging parasitic disease in patients with human immunodeficiency virus type 1 infection in Taiwan . Arch Intern Med . 2005;165:409–415
  34. Wang SF , Liu SC , Lin SF , et al.   Analysis and testing for AIDS in 92 homosexuals at a private party . Epidemiology Bulletin of Center for Diseases Control, Department of Health, Taiwan . 2004;20:105–120
  35. Ko NY , Lee HC , Chang JL , et al.   Prevalence of human immunodeficiency virus and sexually transmitted infections and risky sexual behaviors among men visiting gay bathhouses in Taiwan . Sex Transm Dis . 2006;33:467–473

PII: S0929-6646(08)60106-0

doi:10.1016/S0929-6646(08)60106-0

Journal of the Formosan Medical Association
Volume 107, Issue 5 , Pages 404-411, May 2008